ArticleCells2020

Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defend Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells.

Nicoleta Alexandru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.